🇺🇸 FDA
Pipeline program

MT-1186

MT-1186-Z-101

Phase 1 small_molecule completed

Quick answer

MT-1186 for Healthy Adult Subjects is a Phase 1 program (small_molecule) at Tanabe Pharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Tanabe Pharma
Indication
Healthy Adult Subjects
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials